Suvretta Capital Management 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 96 US equity positions worth $2.8bn in its Q3 2024 13F filing. The largest position was BHVN at 9.3% of the reported book, followed by KURA and INSM. Against the Q2 2024 filing, it opened 8 new positions, added to 16 and reduced 16 among the top 50 holdings.
What did Suvretta Capital Management own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BHVN BIOHAVEN LTD | Healthcare | 9.3% | $259.8m | 5,199,219 | 0% | held |
| 2 | KURA KURA ONCOLOGY INC | Healthcare | 5.4% | $149.5m | 7,652,782 | 8% | added |
| 3 | INSM INSMED INC | Healthcare | 4.3% | $119.4m | 1,635,709 | -35% | reduced |
| 4 | INTRA-CELLULAR THERAPIES INC | 3.8% | $105.3m | 1,439,026 | -8% | reduced | |
| 5 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 3.6% | $99.7m | 10,721,511 | 7% | added |
| 6 | META META PLATFORMS INC | Communication Services | 3.5% | $96.4m | 168,488 | 1% | added |
| 7 | UNH UNITEDHEALTH GROUP INC | Healthcare | 3.1% | $85.9m | 146,845 | -9% | reduced |
| 8 | BENITEC BIOPHARMA INC | 2.9% | $81.1m | 8,829,053 | 422% | added | |
| 9 | AAPL APPLE INC | Technology | 2.8% | $78.3m | 336,147 | -7% | reduced |
| 10 | AMZN AMAZON COM INC | Consumer Cyclical | 2.4% | $65.6m | 352,069 | -1% | reduced |
| 11 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2.3% | $64.0m | 1,151,314 | -44% | reduced |
| 12 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 2.2% | $60.6m | 348,742 | -1% | reduced |
| 13 | 89BIO INC | 2.1% | $59.1m | 7,991,644 | -1% | reduced | |
| 14 | APO APOLLO GLOBAL MGMT INC | Financial Services | 2.1% | $58.1m | 465,050 | 31% | added |
| 15 | ARCELLX INC | 2.1% | $57.6m | 689,950 | -54% | reduced | |
| 16 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.0% | $56.9m | 346,575 | 0% | held |
| 17 | SBUX STARBUCKS CORP | Consumer Cyclical | 1.9% | $53.6m | 550,309 | – | new |
| 18 | GS GOLDMAN SACHS GROUP INC | Financial Services | 1.9% | $53.6m | 108,308 | 39% | added |
| 19 | RPRX ROYALTY PHARMA PLC | Healthcare | 1.9% | $52.8m | 1,866,361 | 0% | held |
| 20 | TSLA TESLA INC | Consumer Cyclical | 1.8% | $50.7m | 193,842 | 44% | added |
| 21 | T AT&T INC | Communication Services | 1.8% | $50.3m | 2,285,336 | 5% | added |
| 22 | CRH CRH PLC | Basic Materials | 1.8% | $50.0m | 538,894 | 25% | added |
| 23 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.8% | $48.8m | 4,212,005 | 0% | held | |
| 24 | FERG FERGUSON ENTERPRISES INC | Industrials | 1.6% | $44.7m | 225,210 | – | new |
| 25 | AVBP ARRIVENT BIOPHARMA INC | 1.6% | $43.4m | 1,845,162 | 8% | added | |
| 26 | KO COCA COLA CO | Consumer Defensive | 1.5% | $42.3m | 588,912 | 5% | added |
| 27 | MSFT MICROSOFT CORP | Technology | 1.5% | $41.5m | 96,526 | -7% | reduced |
| 28 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.5% | $41.4m | 5,175,823 | 0% | held |
| 29 | ORCL ORACLE CORP | Technology | 1.4% | $40.4m | 237,094 | -3% | reduced |
| 30 | GE GE AEROSPACE | Industrials | 1.4% | $37.8m | 200,662 | -2% | reduced |
| 31 | ERAS ERASCA INC | Healthcare | 1.3% | $37.6m | 13,768,039 | 0% | held |
| 32 | COF CAPITAL ONE FINL CORP | Financial Services | 1.3% | $35.3m | 235,600 | – | new |
| 33 | CRWD CROWDSTRIKE HLDGS INC | Technology | 1.2% | $34.3m | 122,155 | – | new |
| 34 | VZ VERIZON COMMUNICATIONS INC | Communication Services | 1.2% | $34.1m | 758,674 | 24% | added |
| 35 | CTNM CONTINEUM THERAPEUTICS INC | 1.2% | $32.9m | 1,720,000 | -16% | reduced | |
| 36 | MCD MCDONALDS CORP | Consumer Cyclical | 1.1% | $31.6m | 103,638 | -6% | reduced |
| 37 | BIOA BIOAGE LABS INC | 1.1% | $30.3m | 1,455,000 | – | new | |
| 38 | KDP KEURIG DR PEPPER INC | Consumer Defensive | 0.9% | $26.4m | 703,095 | – | new |
| 39 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.9% | $24.9m | 7,187,495 | -7% | reduced |
| 40 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 0.9% | $24.4m | 484,110 | – | new |
| 41 | PROK PROKIDNEY CORP | 0.9% | $23.7m | 12,341,266 | 32% | added | |
| 42 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 0.8% | $23.3m | 3,685,503 | 0% | held |
| 43 | JNJ JOHNSON & JOHNSON | Healthcare | 0.8% | $22.4m | 138,447 | 54% | added |
| 44 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.8% | $21.1m | 251,689 | 0% | held |
| 45 | PINS PINTEREST INC | Communication Services | 0.7% | $19.9m | 615,911 | 50% | added |
| 46 | ZURA ZURA BIO LTD | Healthcare | 0.7% | $19.7m | 4,860,939 | 0% | held |
| 47 | PEPG PEPGEN INC | Healthcare | 0.5% | $14.2m | 1,660,932 | 9% | added |
| 48 | GLUE MONTE ROSA THERAPEUTICS INC | 0.5% | $14.1m | 2,659,000 | 0% | held | |
| 49 | WYNN WYNN RESORTS LTD | Consumer Cyclical | 0.5% | $12.8m | 133,000 | – | new |
| 50 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 0.4% | $10.1m | 663,603 | -31% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.